SETTING SCOLIOSIS STRAIGHT FOUNDATION (EIN 262957475) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2008

Legal Domicile

Principal Officer

SUKEN SHAH MD

Phone

6198101430

Tax Period

2024-01-01 to 2024-12-31

SETTING SCOLIOSIS STRAIGHT FOUNDATION, founded in 2008, is a community nonprofit in the Medical Research sector that reported $2.7M in total revenue in fiscal year 2024. Revenue grew 16% year-over-year, indicating healthy expansion. The organization ran a surplus of $886K, a strong 32% operating margin.

Mission

THE SPECIFIC PURPOSES OF THIS CORPORATION ARE TO ADVANCE THE ART AND SCIENCE OF MEDICINE IN THE SPECIALITY OF ORTHOPEDICS WITH AN EMPHASIS ON SPINAL DEFORMITIES IN PEDIATRICS BY FURTHERING EDUCATION OF MEDICAL PRACTITIONERS AND PATIENTS, SUPPORTING AND CONDUCTING RESEARCH PROJECTS AND CLINICAL ACTIVITIES, AND ENGAGING IN ANY OTHER RELATED ACTIVITIES IN FURTHERANCE OF THESE CHARITABLE, EDUCATIONAL AND PUBLIC PURPOSES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $399,255

Program Service Revenue $1,786,752

Investment Income $613,646

Other Revenue $-53,901

TOTAL REVENUE $2,745,752

Expense Breakdown

Grants Paid $0

Salaries & Benefits $962,312

Fundraising Expenses $37,648

Program Expenses $1,426,764

Other Expenses $897,682

TOTAL EXPENSES $1,859,994

Year-over-Year Comparison

	2024	2023	Change
Revenue	$2,745,752	$2,360,424	+0.2%
Expenses	$1,859,994	$1,917,231	0.0%
Net Income	$885,758	$443,193	+1.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$210,087

Total Directors

$210,087

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MICHELLE MARKS	Secretary	40.00	Officer Director	$210,087	$0	$210,087
SUKEN SHAH MD	President	1.00	Officer Director	$0	$0	$0
FIROZ MIYANJI MD	VP OF RESEARCH	1.00	Director	$0	$0	$0
AMER SAMDANI MD	VP OF EDUCATION	1.00	Director	$0	$0	$0
PETER NEWTON MD	Executive Dir.	1.00	Director	$0	$0	$0
DAVID CLEMENTS MD	Executive Dir.	1.00	Director	$0	$0	$0
ROBERT STONE	Treasurer	1.00	Officer Director	$0	$0	$0
RANDAL BETZ MD	Executive Dir.	1.00	Director	$0	$0	$0
HARRY SHUFFLEBARGER MD	Executive Dir.	1.00	Director	$0	$0	$0
THOMAS ERRICO MD	Director	1.00	Director	$0	$0	$0
KEVIN SAYER	Director	1.00	Director	$0	$0	$0
STACEY GOLDFARB	Director	1.00	Director	$0	$0	$0
BARON LONNER MD	Director	1.00	Director	$0	$0	$0
LAWRENCE LENKE MD	Director	1.00	Director	$0	$0	$0
THERESA CHESNUT	Director	1.00	Director	$0	$0	$0
ROSS SYLVIA	Director	1.00	Director	$0	$0	$0
BURT YASZAY MD	Director	1.00	Director	$0	$0	$0
NOELLE LARSON MD	Director	1.00	Director	$0	$0	$0
DAVE POLEY	Director	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$2,745,752	$1,859,994	$6,864,199	$885,758
2023	$2,360,424	$1,917,231	$5,919,819	$443,193
2022	$962,955	$1,607,410	$5,483,199	$-644,455
2021	$2,209,853	$1,804,808	$6,149,373	$405,045
2020	$2,323,024	$1,781,181	$5,965,336	$541,843
2019	$2,400,228	$1,849,550	$5,349,855	$550,678
2018	$2,114,315	$1,760,953	$4,787,466	$353,362

SETTING SCOLIOSIS STRAIGHT FOUNDATION